Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers.

J Clin Med · 2020 · PMC7563385 · PMID 32899345

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

9.2 months; p -value 0.0615); differences did not reach statistical significance (odd ratio (OR) 1.04 (95% CI 0.99–1.08); p -value 0.066).

also in 111,027 other papers

showed a trendno p-value reported

DDR wild-type) showed a trend towards improved partial response rate (21.4% vs. 15.9%), radiological benefit (64.3% vs. 36.2%) and OS benefit (OStreatment: median 20.4 months (95% CI 7.9–26.7) vs. 13.3 (95% CI 11.0–16.4); Cox Regression HR 0.79 (95% CI 0.39–1.61), p -value 0.527) ( Figure 5 , Supplementary Materials 6 ). 4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.